Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
FEBS Letters|July 19, 2011
Transcriptome profiling reveals a novel role for trichostatin A in antagonizing histone chaperone Chz1 mediated telomere anti-silencingYakun Wan, Weiming Chen, Jie Xing, et al.Molecular and Cellular Biology|March 11, 2009
Role of the histone variant H2A.Z/Htz1p in TBP recruitment, chromatin dynamics, and regulated expression of oleate-responsive genesYakun Wan, Ramsey A Saleem, Alexander V Ratushny, et al.Cell|March 5, 2013
A role for the nucleoporin Nup170p in chromatin structure and gene silencingDavid W Van de Vosse, Yakun Wan, Diego L Lapetina, et al.Respiratory Research|November 19, 2022
Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthmaLinlin Ma, Min Zhu, Guanghui Li, et al.Frontiers in Immunology|August 13, 2024
Development and validation of a predictive model assessing the risk of sarcopenia in rheumatoid arthritis patientsYuan Qu, Lili Zhang, Yuan Liu, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 11, 2022
Preclinical evaluation of [<sup>99m</sup>Tc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECT/CTTianyu Liu, Yue Wu, Linqing Shi, et al.Cells|November 11, 2022
Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike ProteinQianling Su, Wei Shi, Xianing Huang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 18, 2025
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8<sup>+</sup> T cell and evading IL-18BP in preclinical modelsYanyang Nan, Min Zhu, Qian Wang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 21, 2025
Continuous Suppression of Pathological Retinal and Choroidal Neovascularization in Cynomolgus Monkeys via Noninvasive Ophthalmic Delivery of a Novel Anti-VEGFA Nanobody and Proprietary Penetratin Analog FormulationChong Chen, Min Zhu, Xingyan Fan, et al.Journal of Nanobiotechnology|November 6, 2023
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancerCaili Xu, Min Zhu, Qian Wang, et al.Pageof 8